Observational studyMedicine2020

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.